2026 NPPES data Addiction (Substance Use Disorder) Counselor NPI 1831310309 APN, LPC, LCADC
Verify on CMS →

ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC

Addiction (Substance Use Disorder) Counselor in PRINCETON, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
871
Medicare Part D claims · 73 beneficiaries · Addiction (Substance Use Disorder) Counselor avg: 645
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.3K
67 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC filed 871 Medicare Part D claims in 2023 as a Addiction (Substance Use Disorder) Counselor in PRINCETON, New Jersey, prescribing 90% generic.

871
Part D claims, 2023
90%
generic prescribing
$1.3K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

871 Top 27% higher than 73% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC?

Quality data not reported

NPI registry status

Active

Issued 05/01/2007

NPI 1831310309

Primary specialty

Addiction (Substance Use Disorder) Counselor

High-volume

109,141 US NPIs in this specialty

Medicare Part D claims

871 35% vs specialty avg

2023 prescription claims

Specialty avg: 645

Specialty distribution in New Jersey

How Addiction (Substance Use Disorder) Counselor compares to other specialties among New Jersey providers

New Jersey providers

Addiction (Substance Use Disorder) Counselor share within New Jersey

1. Addiction (Substance Use Disorder) Counselor42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Addiction (Substance Use Disorder) Counselor share within New Jersey

Specialty board-certification context

Estimated specialty board-certified rate — Addiction (Substance Use Disorder) Counselor (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Addiction (Substance Use Disorder) Counselor ABMS/AOA estimate

Est. board-certified rate (Addiction (Substance Use Disorder) Counselor) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Addiction (Substance Use Disorder) Counselor) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC appears in the CMS NPPES registry as a Addiction (Substance Use Disorder) Counselor provider holding APN, LPC, LCADC credentials at 12 ROSZEL RD STE A103, PRINCETON, NJ, 08540, with a listed phone of (609) 419-0123. NPI 1831310309 was issued on 05/01/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TRAPANI-BARNACZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 871 prescription claims written by this provider, covering 73 Medicare beneficiaries and totaling roughly $159K in drug spend, split 10% brand-name and 90% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Addiction (Substance Use Disorder) Counselor is a high-volume specialty nationwide, with 109,141 enrolled providers across 55 states and an average of 645 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

12 ROSZEL RD STE A103
PRINCETON, NJ 08540

Provider Details

NPI 1831310309
Specialty Addiction (Substance Use Disorder) Counselor
Credentials APN, LPC, LCADC
Gender Female
NPI Issued 05/01/2007

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC. Source: openpaymentsdata.cms.gov.

Total received

$1.3K

Largest payer

ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC — brand share 10.0%
Specialty average (est.)

10% brand-name claims vs 90% generic, on 871 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

871
Total Claims
$159K
Total Drug Cost
73
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,691
Total Day Supply
50,272
Brand vs Generic
10% brand / 90% generic
Brand Drug Cost
$129K
Generic Drug Cost
$31K

Patient Demographics

Average Patient Age
69.8 years
Avg HCC Risk Score
1.08
Gender Split
53% female / 47% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Lamotrigine
112
Clonazepam
94
Duloxetine Hcl
49
Buspirone Hcl
39
Bupropion Xl
Bupropion Hcl
35
Desvenlafaxine Succinate Er
Desvenlafaxine Succinate
35
Gabapentin
29
Levothyroxine Sodium
27
Aripiprazole
26
Escitalopram Oxalate
23

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Addiction (Substance Use Disorder) Counselor Overview

How ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC fits within the Addiction (Substance Use Disorder) Counselor landscape nationally.

109,141
Addiction (Substance Use Disorder) Counselor Providers in US
55
States with Addiction (Substance Use Disorder) Counselor
645
Avg Claims per Provider

ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC's 871 claims are above the specialty average of 645.

Nearby Addiction (Substance Use Disorder) Counselor Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as TRAPANI-BARNACZ.

Compare Addiction (Substance Use Disorder) Counselor nationally: see state-by-state distribution →

Frequently Asked Questions

What is ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC's specialty?
ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC specializes in Addiction (Substance Use Disorder) Counselor and practices in PRINCETON, New Jersey. Credentials: APN, LPC, LCADC.
How much does ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC prescribe under Medicare Part D?
In 2023, ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC wrote 871 Medicare Part D claims totaling $159K in drug costs for 73 beneficiaries.
Where is ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC located?
ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC is located at 12 ROSZEL RD STE A103, PRINCETON, NJ, 08540. Phone: (609) 419-0123.
What is ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC's NPI number?
ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC's National Provider Identifier (NPI) is 1831310309, issued on 05/01/2007.
Does ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC prescribe more brand-name or generic drugs?
ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC's prescribing is 10% brand-name and 90% generic drugs by claim count, with $129K in brand drug costs.
How many Addiction (Substance Use Disorder) Counselor providers are there in the US?
There are 109,141 Addiction (Substance Use Disorder) Counselor providers across 55 states in the US. The average Addiction (Substance Use Disorder) Counselor provider writes 645 Medicare Part D claims per year.
What drugs does ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC prescribe most often?
Based on 2023 Medicare Part D data, ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC's most frequently prescribed drugs include Lamotrigine, Clonazepam, Duloxetine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC accept Medicare?
ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC appears in CMS Medicare data with 871 Part D claims and 73 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC's credentials?
ADRIA TRAPANI-BARNACZ, APN, LPC, LCADC's NPI is 1831310309 with credentials APN, LPC, LCADC. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology